Publications by authors named "Elaine Esler"
Semin Oncol Nurs
October 2024
Article Synopsis
- Talquetamab is a newly approved bispecific antibody that targets T cells and is specifically effective against multiple myeloma (MM), but it can cause unique side effects related to skin, nails, and oral health that need careful management.
- The review discusses findings from the MonumenTAL-1 clinical trial, which reported over 71% effectiveness in patients with relapsed/refractory MM, highlighting that most adverse events were low-grade and manageable.
- It emphasizes the crucial role of oncology nurses in monitoring and supporting patient care related to talquetamab treatment, aiming to enhance the quality of life and survival rates for patients undergoing this therapy.
